WLK (WLK) Price Target
Track Wall Street analyst price targets and coverage changes.
Consensus Price Target
$159.75
▲
58.3%
Upside
based on current price $100.89
High Target
$180.00
Median Target
$162.00
Low Target
$135.00
Analyst Coverage
Last Month
0
$0.00
Last Quarter
1
$135.00
Last Year
17
$164.94
Individual Price Targets
Latest Analyst Coverage
| Date | Analyst | Firm | Target | Price When Posted | Upside | News |
|---|---|---|---|---|---|---|
| Jan 10, 2025 | David Begleiter | Deutsche Bank | $135.00 | $110.04 | 22.7% | Westlake price target lowered to $135 from $165 at Deutsche Bank |
| Nov 13, 2024 | John McNulty | BMO Capital | $165.00 | $145.99 | 13.0% | Westlake Chemical (WLK) PT Lowered to $165 at BMO Capital |
| Oct 16, 2024 | Steve Byrne | Bank of America Securities | $159.00 | $141.80 | 12.1% | BofA Securities Upgrades Westlake Chemical (WLK) to Neutral |
| Sep 30, 2024 | Michael Leithead | Barclays | $180.00 | $150.36 | 19.7% | Barclays Upgrades Westlake Chemical (WLK) to Overweight |
| Sep 05, 2024 | Charles Neivert | Piper Sandler | $170.00 | $137.56 | 23.6% | Westlake price target lowered to $170 from $180 at Piper Sandler |
| Aug 26, 2024 | Duffy Fischer | Goldman Sachs | $162.00 | $150.97 | 7.3% | Goldman Sachs Reiterates Neutral Rating on Westlake Chemical (WLK) |
| Aug 23, 2024 | Arun Viswanathan | RBC Capital | $174.00 | $144.58 | 20.3% | Westlake upgraded to Outperform from Sector Perform at RBC Capital |
| Aug 13, 2024 | John McNulty | BMO Capital | $171.00 | $142.62 | 19.9% | Westlake price target raised to $171 from $167 at BMO Capital |
| Aug 06, 2024 | Pat Cunningham | Citigroup | $154.00 | $146.53 | 5.1% | Citi Reiterates Neutral Rating on Westlake Chemical (WLK) |
| Jul 09, 2024 | Joshua Spector | UBS | $160.00 | $142.29 | 12.4% | Westlake price target lowered to $160 from $172 at UBS |
| Jun 17, 2024 | John McNulty | BMO Capital | $167.00 | $150.37 | 11.1% | BMO Capital Reiterates Market Perform Rating on Westlake Chemical (WLK) |
| Jun 17, 2024 | Michael Leithead | Barclays | $162.00 | $149.83 | 8.1% | Westlake price target raised to $162 from $160 at Barclays |
| Jun 14, 2024 | Arun Viswanathan | RBC Capital | $158.00 | $149.84 | 5.4% | RBC Capital Reiterates Sector Perform Rating on Westlake Chemical (WLK) |
| May 07, 2024 | Charles Neivert | Piper Sandler | $180.00 | $156.47 | 15.0% | Westlake Chemical (WLK) PT Raised to $180 at Piper Sandler |
| Apr 19, 2024 | Arun Viswanathan | RBC Capital | $153.00 | $148.94 | 2.7% | Westlake price target raised to $153 from $134 at RBC Capital |
| Apr 18, 2024 | David Begleiter | Deutsche Bank | $174.00 | $148.59 | 17.1% | Deutsche Bank Upgrades Westlake Chemical (WLK) to Buy |
| Apr 03, 2024 | Michael Sison | Wells Fargo | $180.00 | $153.48 | 17.3% | Westlake Chemical (WLK) PT Raised to $180 at Wells Fargo |
Related Metrics
Explore detailed financial metrics and analysis for WLK.